Fortrea
Runs clinical trials and development services for drug, biotech, and device sponsors.
$18.89
After-hours close+0.09 (+0.51%)
At close$18.80(−0.34%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 109.48%Insiders 0.94%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 95.10M · Float 94.21M · 99.1% free float
Institutions13F, as of Jun 30, 2026
336 holders · 104.11M shares · 47 new positions · 144 increased · 109 reduced · 45 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.80M | 16.61% | +646.7K | Aug 7, 2026 |
| Goldman Sachs Group Inc | 8.41M | 8.85% | +315.5K | Aug 14, 2026 |
| Sessa Capital Im, L.P. | 4.59M | 4.83% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.18M | 4.40% | +143.0K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.82M | 4.01% | +119.9K | Aug 13, 2026 |
| State Street Corp | 3.78M | 3.98% | −325.2K | Aug 7, 2026 |
| FMR LLC | 3.65M | 3.83% | +2.40M | Aug 13, 2026 |
| Corvex Management LP | 2.99M | 3.14% | −1.66M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.30% | 13.81M | 13G | Jul 17, 2025 ↗ |
| The Goldman Sachs Group, Inc. | 8.90% | 8.03M | 13G | Aug 13, 2025 ↗ |
| Vanguard Capital Management | 5.05% | 4.73M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Peter M. Neupert | director | 246.7K | 0.26% | May 18, 2026 |
| Anshul Thakral | director, officer: Chief Executive Officer | 204.9K | 0.22% | Aug 7, 2026 |
| Mark A. Morais | officer: Chief Operating Officer | 77.8K | 0.08% | Aug 19, 2026 |
| Erin L. Russell | director | 72.6K | 0.08% | Jun 12, 2026 |
| Jill G. Mcconnell | officer: Chief Financial Officer | 72.3K | 0.08% | Mar 17, 2026 |
| Edward A. Pesicka | director | 52.5K | 0.06% | Jun 12, 2026 |
| Amrit Ray | director | 52.5K | 0.06% | Jun 12, 2026 |
| David Ross Smith | director | 36.7K | 0.04% | Jul 27, 2026 |
| Machelle Sanders | director | 36.4K | 0.04% | Aug 5, 2026 |
| Robert Parks | officer: Chief Accounting Officer | 20.4K | 0.02% | May 20, 2026 |
7 people have not refiled in the last 18 months (236.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 4,892 | $18.19 | 77,786 |
| Aug 6, 2026 | Anshul Thakraldirector, officer: Chief Executive Officer | Sale · 2 lots | 111,857 | $18.11 | 204,940 |
| Aug 5, 2026 | Anshul Thakraldirector, officer: Chief Executive Officer | Sale · 2 lots | 99,869 | $19.16 | 316,797 |
| Aug 3, 2026 | Machelle Sandersdirector | Sale | 9,700 | $18.01 | 36,399 |
| Jun 10, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 4,674 | $16.82 | 71,365 |
| May 18, 2026 | Robert Parksofficer: Chief Accounting Officer | Sale | 2,000 | $13.44 | 20,389 |
| Mar 16, 2026 | Jill G. Mcconnellofficer: Chief Financial Officer | Sale | 1,804 | $9.22 | 72,276 |
| Mar 16, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 1,804 | $9.22 | 69,899 |
| Mar 10, 2026 | Jill G. Mcconnellofficer: Chief Financial Officer | Sale · 2 lots | 5,061 | $9.07 | 69,796 |
| Mar 10, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale · 2 lots | 4,599 | $9.07 | 67,419 |
CongressHouse and Senate disclosures
Not reported.